NCT00378768View on ClinicalTrials.gov

Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

June 30, 2007

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

anti-thymocyte globulin

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00378768 - Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma | Biotech Hunter | Biotech Hunter